Peptobiotics Secures $6.2M for Marketing Agri-Focused Antibiotic Substitute

Peptobiotics, a Singapore-based startup, has successfully raised US$6.2 million in its Series A funding round. This new capital injection will enable the company to bring its antibiotic alternative for the farming and aquaculture sector to market.

Jonathan Bester, co-founder, and CEO of Peptobiotics, expressed his enthusiasm for the Series A raise, emphasizing that it provides the company with the necessary working capital to scale up production and deliver larger commercial volumes of its product. By doing so, Peptobiotics aims to address the issue of antibiotic overreliance in the food supply chain within the farming and aquaculture space.Founded in 2020, Peptobiotics is on a mission to tackle one of the most urgent challenges facing the agriculture industry: antibiotic resistance. With the overuse of antibiotics in farming and aquaculture contributing to the proliferation of resistant bacteria, Peptobiotics is pioneering innovative solutions to promote sustainable food production.

By developing effective alternatives to antibiotics, the company aims to not only combat antibiotic resistance but also foster healthier farming practices that prioritize animal welfare and environmental sustainability.The recent series A funding round, which raised US$6.2 million, marks a significant milestone for Peptobiotics. This infusion of capital provides the company with the necessary resources to scale up its operations and bring its antibiotic alternative to market on a larger scale. With the support of investors such as Hatch Blue, Seeds Capital, Seventure Partners, GrainCorp Ventures, and Farmabase, Peptobiotics is well-positioned to accelerate its efforts in transforming the agriculture industry.

Peptobiotics' approach centers on the use of recombinant antimicrobial peptides, naturally occurring proteins that inhibit the growth of bacteria. By harnessing biotechnology, the company is developing a real agricultural antibiotic alternative that offers efficacy for farmers, environmental sustainability, humane treatment of animals, and safety for consumers. This innovative solution has the potential to revolutionize farming practices and contribute to the long-term resilience of the global food system.In addition to its focus on technological innovation, Peptobiotics is committed to promoting sustainability across the agriculture sector. By providing farmers with viable alternatives to antibiotics, the company aims to reduce reliance on these medications and minimize their environmental impact.

Furthermore, Peptobiotics prioritizes animal welfare, striving to ensure that its solutions support humane treatment practices in farming and aquaculture operations.Peptobiotics' recent funding round represents not only a financial boost but also an affirmation of its mission to revolutionize the agriculture industry. With its dedication to innovation, sustainability, and animal welfare, Peptobiotics is poised to make a meaningful impact in the fight against antibiotic resistance and the promotion of sustainable food production practices globally.Peptobiotics highlighted the concerning trend in the United States, where approximately 80% of antibiotics are administered to animals.

In response to this issue, the company offers a solution that utilizes recombinant antimicrobial peptides, which are naturally occurring proteins capable of inhibiting bacterial growth.By harnessing the power of these antimicrobial peptides, Peptobiotics aims to provide a sustainable alternative to conventional antibiotics in the farming and aquaculture sectors. This innovative approach not only addresses the overreliance on antibiotics but also contributes to promoting healthier farming practices and reducing the risk of antibiotic resistance in food production systems.Jonathan Bester, the CEO of Peptobiotics, emphasized the company's commitment to leveraging biotechnology to develop a genuine alternative to agricultural antibiotics.

Their goal is to provide a solution that is not only effective for farmers but also environmentally friendly, animal-friendly, and safe for consumers.The oversubscribed Series A funding round was led by Hatch Blue, a prominent aquaculture-focused enterprise. Other participants included Seeds Capital from Singapore, Seventure Partners from France, GrainCorp Ventures from Australia, and Farmabase, a Latin American company specializing in animal healthcare. This diverse group of investors underscores the global interest and support for Peptobiotics' innovative approach to addressing antibiotic overuse in agriculture and aquaculture.